Jane Street’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-237,128
Closed -$8.07M 5589
2025
Q1
$8.07M Sell
237,128
-189,689
-44% -$6.46M ﹤0.01% 999
2024
Q4
$16.8M Buy
426,817
+255,387
+149% +$10.1M ﹤0.01% 500
2024
Q3
$8.05M Sell
171,430
-178,501
-51% -$8.39M ﹤0.01% 895
2024
Q2
$18.9M Buy
349,931
+174,859
+100% +$9.44M ﹤0.01% 672
2024
Q1
$11.9M Sell
175,072
-299,936
-63% -$20.4M ﹤0.01% 725
2023
Q4
$29.7M Buy
475,008
+349,887
+280% +$21.9M 0.01% 388
2023
Q3
$5.68M Buy
125,121
+28,650
+30% +$1.3M ﹤0.01% 1216
2023
Q2
$5.42M Sell
96,471
-37,739
-28% -$2.12M ﹤0.01% 1430
2023
Q1
$6.07M Buy
134,210
+63,620
+90% +$2.88M ﹤0.01% 1049
2022
Q4
$2.87M Buy
70,590
+64,020
+974% +$2.6M ﹤0.01% 1645
2022
Q3
$429K Sell
6,570
-104,845
-94% -$6.85M ﹤0.01% 3777
2022
Q2
$6.77M Buy
111,415
+24,436
+28% +$1.48M ﹤0.01% 887
2022
Q1
$5.46M Sell
86,979
-206,099
-70% -$12.9M ﹤0.01% 1124
2021
Q4
$22.2M Buy
293,078
+43,882
+18% +$3.33M 0.01% 333
2021
Q3
$27.9M Sell
249,196
-162,965
-40% -$18.2M 0.01% 244
2021
Q2
$66.7M Buy
412,161
+47,075
+13% +$7.62M 0.03% 95
2021
Q1
$44.5M Buy
365,086
+180,737
+98% +$22M 0.02% 136
2020
Q4
$28.2M Buy
184,349
+175,906
+2,083% +$26.9M 0.01% 180
2020
Q3
$706K Buy
8,443
+3,549
+73% +$297K ﹤0.01% 2126
2020
Q2
$360K Sell
4,894
-21,656
-82% -$1.59M ﹤0.01% 2858
2020
Q1
$1.13M Buy
26,550
+20,485
+338% +$869K ﹤0.01% 1480
2019
Q4
$370K Buy
+6,065
New +$370K ﹤0.01% 2499
2019
Q3
Sell
-11,907
Closed -$561K 3487
2019
Q2
$561K Buy
11,907
+5,646
+90% +$266K ﹤0.01% 2175
2019
Q1
$224K Sell
6,261
-33,013
-84% -$1.18M ﹤0.01% 2909
2018
Q4
$1.12M Sell
39,274
-48,352
-55% -$1.38M ﹤0.01% 1350
2018
Q3
$3.89M Buy
87,626
+77,674
+780% +$3.44M 0.01% 661
2018
Q2
$585K Sell
9,952
-9,421
-49% -$554K ﹤0.01% 2138
2018
Q1
$886K Buy
+19,373
New +$886K ﹤0.01% 1681